KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Common Equity (2019 - 2025)

Historic Common Equity for Hims & Hers Health (HIMS) over the last 7 years, with Q3 2025 value amounting to $581.0 million.

  • Hims & Hers Health's Common Equity rose 3202.61% to $581.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $581.0 million, marking a year-over-year increase of 3202.61%. This contributed to the annual value of $476.7 million for FY2024, which is 3856.86% up from last year.
  • As of Q3 2025, Hims & Hers Health's Common Equity stood at $581.0 million, which was up 3202.61% from $562.7 million recorded in Q2 2025.
  • Over the past 5 years, Hims & Hers Health's Common Equity peaked at $581.0 million during Q3 2025, and registered a low of $292.5 million during Q1 2021.
  • In the last 5 years, Hims & Hers Health's Common Equity had a median value of $334.6 million in 2021 and averaged $377.2 million.
  • In the last 5 years, Hims & Hers Health's Common Equity skyrocketed by 700305.57% in 2021 and then plummeted by 1244.73% in 2022.
  • Hims & Hers Health's Common Equity (Quarter) stood at $334.6 million in 2021, then dropped by 6.84% to $311.7 million in 2022, then rose by 10.36% to $344.0 million in 2023, then skyrocketed by 38.57% to $476.7 million in 2024, then grew by 21.87% to $581.0 million in 2025.
  • Its Common Equity stands at $581.0 million for Q3 2025, versus $562.7 million for Q2 2025 and $549.3 million for Q1 2025.